Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,5 Dihydroxybenzenesulfonate
2. 2,5 Dihydroxybenzenesulfonic Acid
3. 2,5-dihydroxybenzenesulfonate
4. 2,5-dihydroxybenzenesulfonic Acid
5. Calcium Dobesilate (1:1)
6. Calcium Dobesilate Monoammonium Salt
7. Calcium Dobesilate Monopotassium Salt
8. Calcium, Dobesilate
9. Dexium
10. Dobesilate Calcium
11. Dobesilate, Calcium
12. Dobica
13. Doxium
1. 20123-80-2
2. Dexium
3. Dobesilate Calcium
4. Doxium
5. Calcium 2,5-dihydroxybenzenesulfonate
6. Hydroquinone Calcium Sulfonate
7. Calcium Dobesilate [inn]
8. 205 E
9. Benzenesulfonic Acid, 2,5-dihydroxy-, Calcium Salt (2:1)
10. 2,5-dihydroxybenzenesulfonic Acid Calcium Salt
11. Calcium Doxybensylate
12. Calcii Dobesilas
13. 205-e
14. 5921x1560q
15. Calcium Dobesilate (inn)
16. Dobesilato Calcico
17. Doxi-om
18. Dobesilate De Calcium
19. Calcium Bis(2,5-dihydroxybenzenesulfonate)
20. Calcium Dobesilate Hydrate
21. Calciumdobesilate
22. Calcium Hydrochinonsulfonat
23. Dobesilato Calcio
24. Dobesilato Di Calcio [dcit]
25. Dobesilato Di Calcio
26. Calcii Dobesilas [inn-latin]
27. Dobesilato Calcio [inn-spanish]
28. Dobesilate De Calcium [inn-french]
29. Einecs 243-531-5
30. Calcium Bis(2,5-dihydroxybenzolsulfonat)
31. Unii-5921x1560q
32. Doxium (tn)
33. Calcium Dobesilate,(s)
34. Schembl148396
35. Benzenesulfonic Acid, 2,5-dihydroxy-, Calcium Salt
36. 2,5-dihydroxybenzenesulfonic Acid Calcium Salt (2:1)
37. Dobesilate Calcium [mi]
38. Chembl2106191
39. Exo-2-aminonorbornane99
40. Dtxsid60173946
41. Bcp13786
42. Calcium Dobesilate [who-dd]
43. Akos005267175
44. Dobesilate Calcium, >=98% (hplc)
45. Calcium 2,5-bis(oxidanyl)benzenesulfonate
46. Db-045100
47. Hy-111603
48. Cs-0088365
49. Ft-0625554
50. Calcium 2,5-dihydroxybenzenesulphonate
51. D07427
52. D70205
53. A814261
54. J-013032
55. Q5018825
Molecular Weight | 418.4 g/mol |
---|---|
Molecular Formula | C12H10CaO10S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 0 |
Exact Mass | 417.9341297 g/mol |
Monoisotopic Mass | 417.9341297 g/mol |
Topological Polar Surface Area | 212 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 228 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
C - Cardiovascular system
C05 - Vasoprotectives
C05B - Antivaricose therapy
C05BX - Other sclerosing agents
C05BX01 - Calcium dobesilate
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Doxium Strong
Dosage Form : Hard Capsule
Dosage Strength : 500MG
Packaging :
Approval Date : 1979-03-01
Application Number : 54553
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Calcium Dobesylate Monohydrate
Brand Name : Qualigen Calcium Dobesilyate
Dosage Form : Hard Capsule
Dosage Strength : 500MG
Packaging :
Approval Date : 2018-02-16
Application Number : 82868
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Allowed
Registration Country : Switzerland
Calcium Dobesilase Monohydrate; Lidocaine Hydrochloride Monohydrate
Brand Name : Doxiproct
Dosage Form : Rectal Ointment
Dosage Strength :
Packaging :
Approval Date : 02/04/1975
Application Number : 38932
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Calcium Dobesilate Monohydrate
Brand Name : Doxium
Dosage Form : Capsule
Dosage Strength : 500mg
Packaging :
Approval Date : 15/12/1975
Application Number : 39217
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Calcium Dobesilate Monohydrate
Brand Name : Doxium
Dosage Form : Film Coated Tablet
Dosage Strength : 1000mg
Packaging :
Approval Date : 20/04/2011
Application Number : 61059
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Calcium Dobesilate Monohydrate
Brand Name : Doxocur
Dosage Form : Capsule
Dosage Strength : 500mg
Packaging :
Approval Date : 26/01/2023
Application Number : 69172
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Calcium Dobesilate Monohydrate; Lidocaine Hydrochloride Monohydrate; Dexamethasone Acetate
Brand Name : Doxiproct Plus
Dosage Form : Rectal Ointment
Dosage Strength :
Packaging :
Approval Date : 22/04/1975
Application Number : 38934
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Cancelled
Registration Country : Spain
Calcium Dobesylate Monohydrate
Brand Name : Dobesilato Calcico Dari Pharma
Dosage Form : Hard Capsule
Dosage Strength : 500MG
Packaging :
Approval Date : 2018-02-16
Application Number : 82867
Regulatory Info : Cancelled
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Cancelled
Registration Country : Spain
Calcium Dobesylate Monohydrate
Brand Name : Asilant
Dosage Form : Hard Capsule
Dosage Strength : 500MG
Packaging :
Approval Date : 2018-02-16
Application Number : 82869
Regulatory Info : Cancelled
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
ABOUT THIS PAGE
74
PharmaCompass offers a list of Calcium Dobesilate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Dobesilate manufacturer or Calcium Dobesilate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Dobesilate manufacturer or Calcium Dobesilate supplier.
PharmaCompass also assists you with knowing the Calcium Dobesilate API Price utilized in the formulation of products. Calcium Dobesilate API Price is not always fixed or binding as the Calcium Dobesilate Price is obtained through a variety of data sources. The Calcium Dobesilate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sanofi Synthelabo Brand of Calcium Dobesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sanofi Synthelabo Brand of Calcium Dobesilate, including repackagers and relabelers. The FDA regulates Sanofi Synthelabo Brand of Calcium Dobesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sanofi Synthelabo Brand of Calcium Dobesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sanofi Synthelabo Brand of Calcium Dobesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sanofi Synthelabo Brand of Calcium Dobesilate supplier is an individual or a company that provides Sanofi Synthelabo Brand of Calcium Dobesilate active pharmaceutical ingredient (API) or Sanofi Synthelabo Brand of Calcium Dobesilate finished formulations upon request. The Sanofi Synthelabo Brand of Calcium Dobesilate suppliers may include Sanofi Synthelabo Brand of Calcium Dobesilate API manufacturers, exporters, distributors and traders.
click here to find a list of Sanofi Synthelabo Brand of Calcium Dobesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sanofi Synthelabo Brand of Calcium Dobesilate Drug Master File in Korea (Sanofi Synthelabo Brand of Calcium Dobesilate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sanofi Synthelabo Brand of Calcium Dobesilate. The MFDS reviews the Sanofi Synthelabo Brand of Calcium Dobesilate KDMF as part of the drug registration process and uses the information provided in the Sanofi Synthelabo Brand of Calcium Dobesilate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sanofi Synthelabo Brand of Calcium Dobesilate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sanofi Synthelabo Brand of Calcium Dobesilate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sanofi Synthelabo Brand of Calcium Dobesilate suppliers with KDMF on PharmaCompass.
A Sanofi Synthelabo Brand of Calcium Dobesilate written confirmation (Sanofi Synthelabo Brand of Calcium Dobesilate WC) is an official document issued by a regulatory agency to a Sanofi Synthelabo Brand of Calcium Dobesilate manufacturer, verifying that the manufacturing facility of a Sanofi Synthelabo Brand of Calcium Dobesilate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sanofi Synthelabo Brand of Calcium Dobesilate APIs or Sanofi Synthelabo Brand of Calcium Dobesilate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sanofi Synthelabo Brand of Calcium Dobesilate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sanofi Synthelabo Brand of Calcium Dobesilate suppliers with Written Confirmation (WC) on PharmaCompass.
Sanofi Synthelabo Brand of Calcium Dobesilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sanofi Synthelabo Brand of Calcium Dobesilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sanofi Synthelabo Brand of Calcium Dobesilate GMP manufacturer or Sanofi Synthelabo Brand of Calcium Dobesilate GMP API supplier for your needs.
A Sanofi Synthelabo Brand of Calcium Dobesilate CoA (Certificate of Analysis) is a formal document that attests to Sanofi Synthelabo Brand of Calcium Dobesilate's compliance with Sanofi Synthelabo Brand of Calcium Dobesilate specifications and serves as a tool for batch-level quality control.
Sanofi Synthelabo Brand of Calcium Dobesilate CoA mostly includes findings from lab analyses of a specific batch. For each Sanofi Synthelabo Brand of Calcium Dobesilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sanofi Synthelabo Brand of Calcium Dobesilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sanofi Synthelabo Brand of Calcium Dobesilate EP), Sanofi Synthelabo Brand of Calcium Dobesilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sanofi Synthelabo Brand of Calcium Dobesilate USP).